Concord Drugs submits copy of rectification on financial results

11 Sep 2015 Evaluate

Concord Drugs has submitted a copy of Rectified Financial Results (With Denomination) for the period ended June 30, 2015.

The above information is a part of company’s filings submitted to BSE.

Concord Drugs Share Price

38.00 0.39 (1.04%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.